Novelties in the Field of Anti‐Infective Compounds in 1999
Open Access
- 1 December 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (6) , 1423-1466
- https://doi.org/10.1086/317490
Abstract
In 1999 the number of new compounds reported in the anti-infective field decreased significantly in comparison with previous years, especially for antifungals. The reported new compounds are mainly directed against Staphylococcus aureus isolates resistant to methicillin. Few derivatives were reported in the field of anti-infectives for gram-negative bacteria. At the moment, we are in a period of discovery as we await novel compounds that could issue from new engineering.Keywords
This publication has 69 references indexed in Scilit:
- Antifungal peptides: potential candidates for the treatment of fungal infectionsExpert Opinion on Investigational Drugs, 2000
- Antifungal agents with protein biosynthesis inhibitory activityDrugs of the Future, 2000
- Synthesis and biological evaluation of novel 1β-methylcarbapenems having a new moiety at C-2Bioorganic & Medicinal Chemistry Letters, 1999
- Cryptocandin, a potent antimycotic from the endophytic fungus Cryptosporiopsis cf. quercinaMicrobiology, 1999
- RiametDrugs of the Future, 1999
- New targets for antibiotic development: biogenesis of surface adherence structuresDrug Discovery Today, 1998
- Efflux pumps in bacteria: overview, clinical relevance, and potential pharmaceutical targetExpert Opinion on Investigational Drugs, 1998
- Novelties in the field of fluoroquinolonesExpert Opinion on Investigational Drugs, 1997
- Synthesis and structure-activity relationships of novel THF 1β-methylcarbapenemsBioorganic & Medicinal Chemistry Letters, 1997
- A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance 1 1 Edited by T.RichmondJournal of Molecular Biology, 1997